182 related articles for article (PubMed ID: 15958453)
1. Neo-adjuvant therapy in breast cancer.
Bafaloukos D
Ann Oncol; 2005; 16 Suppl 2():ii174-81. PubMed ID: 15958453
[No Abstract] [Full Text] [Related]
2. [Clinical significance and pathological evaluation of neoadjuvant chemotherapy in breast cancer].
Chen LR
Zhonghua Bing Li Xue Za Zhi; 2010 Apr; 39(4):218-21. PubMed ID: 20654118
[No Abstract] [Full Text] [Related]
3. Neoadjuvant systemic therapy for breast cancer: an overview and review of recent clinical trials.
Hanrahan EO; Hennessy BT; Valero V
Expert Opin Pharmacother; 2005 Aug; 6(9):1477-91. PubMed ID: 16086636
[TBL] [Abstract][Full Text] [Related]
4. Controversies in breast cancer: adjuvant and neoadjuvant therapy.
Montemurro F; Redana S; Valabrega G; Aglietta M
Expert Opin Pharmacother; 2005 Jun; 6(7):1055-72. PubMed ID: 15957962
[TBL] [Abstract][Full Text] [Related]
5. [Role of taxanes in treatment of breast cancer].
Gorbunova VA; Besova NS
Vopr Onkol; 2004; 50(4):492-500. PubMed ID: 15605777
[No Abstract] [Full Text] [Related]
6. Herceptin (trastuzumab): adjuvant and neoadjuvant trials.
Yaal-Hahoshen N; Safra T
Isr Med Assoc J; 2006 Jun; 8(6):416-21. PubMed ID: 16833172
[No Abstract] [Full Text] [Related]
7. [Advances in the treatment of breast carcinoma. New therapy schedules with astonishing success quotas].
Aumiller J
MMW Fortschr Med; 2006 Mar; 148(12):4-6, 8. PubMed ID: 16625995
[No Abstract] [Full Text] [Related]
8. Breast cancer (metastatic).
Stebbing J; Glassman R
Clin Evid; 2005 Jun; (13):2197-225. PubMed ID: 16135325
[No Abstract] [Full Text] [Related]
9. When an interim analysis of randomized trial changes the practice in oncology: the lesson of adjuvant Trastuzumab and the HERA trial.
De Rossi C; Brunello A; Jirillo G; Jirillo A
Immunopharmacol Immunotoxicol; 2009 Mar; 31(1):30-1. PubMed ID: 21054206
[TBL] [Abstract][Full Text] [Related]
10. Selected highlights from the 27th San Antonio Breast Cancer Symposium. San Antonio, TX, USA, 8-11 December 2004.
Ponzone R; Sismondi P
Expert Opin Pharmacother; 2005 Jun; 6(7):1257-67. PubMed ID: 15957978
[TBL] [Abstract][Full Text] [Related]
11. Incorporating the antidiabetic drug metformin in HER2-positive breast cancer treated with neo-adjuvant chemotherapy and trastuzumab: an ongoing clinical-translational research experience at the Catalan Institute of Oncology.
Martin-Castillo B; Dorca J; Vazquez-Martin A; Oliveras-Ferraros C; Lopez-Bonet E; Garcia M; Del Barco S; Menendez JA
Ann Oncol; 2010 Jan; 21(1):187-9. PubMed ID: 19884247
[No Abstract] [Full Text] [Related]
12. [Breast cancer: HER2 changes one's cards on the table].
Lopez M
Clin Ter; 2005; 156(5):255-62. PubMed ID: 16382976
[TBL] [Abstract][Full Text] [Related]
13. [Adjuvant chemotherapy for breast cancer and targeted therapies].
Dufresne A; Bachelot T; Blay JY
Rev Prat; 2008 Mar; 58(5):477-8. PubMed ID: 18524101
[No Abstract] [Full Text] [Related]
14. Combining trastuzumab (Herceptin) with hormonal therapy in breast cancer: what can be expected and why?
Jones A
Ann Oncol; 2003 Dec; 14(12):1697-704. PubMed ID: 14630672
[TBL] [Abstract][Full Text] [Related]
15. [New data concerning breast carcinoma. A report on the 34th Meeting of the American Society of Clinical Oncology, Los Angeles, Calif., USA, May 16-19, 1998].
Gerber B; Krause A
Gynakol Geburtshilfliche Rundsch; 1999; 39(3):136-9. PubMed ID: 10420058
[No Abstract] [Full Text] [Related]
16. Neo(adjuvant) trastuzumab treatment: current perspectives.
Iwata H
Breast Cancer; 2009; 16(4):288-94. PubMed ID: 19609648
[TBL] [Abstract][Full Text] [Related]
17. A monoclonal antibody as an effective therapeutic agent in breast cancer: trastuzumab.
Rueckert S; Ruehl I; Kahlert S; Konecny G; Untch M
Expert Opin Biol Ther; 2005 Jun; 5(6):853-66. PubMed ID: 15952915
[TBL] [Abstract][Full Text] [Related]
18. [Adjuvant treatment of operable breast cancer].
Khosravi Shahi P; Izarzugaza Perón Y; Encinas García S; Díaz Muñoz de la Espada VM; Pérez Manga G
An Med Interna; 2008 Jan; 25(1):36-40. PubMed ID: 18377195
[TBL] [Abstract][Full Text] [Related]
19. Individualization of neoadjuvant therapy for breast cancer according to molecular tumor characteristics.
Hennessy BT; Gonzalez-Angulo AM; Hortobagyi GN
Nat Clin Pract Oncol; 2005 Dec; 2(12):598-9. PubMed ID: 16341096
[No Abstract] [Full Text] [Related]
20. [Sequencing of adjuvant treatment after surgery for invasive breast cancer].
Petit T; Claude L; Carrie C
Cancer Radiother; 2004 Feb; 8(1):54-8. PubMed ID: 15093202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
